Evaluation of the physicochemical and functional stability of diluted REMSIMA ® upon extended storage—A study compliant with NHS (UK) guidance-Reference-Cited by-同舟云学术

Evaluation of the physicochemical and functional stability of diluted REMSIMA ® upon extended storage—A study compliant with NHS (UK) guidance

Published:2015-12 Issue:2 Volume:496 Page:421-431
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Young Benjamin L.,Khan Monika Ali,Chapman Terry J.,Parry Richard,Connolly Maria A.,Watts Andrew G.

Funder

Bath ASU

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference8 articles.

1. Role of tumour necrosis factor-alpha inhibition with infliximab in cancer therapy and hematopoietic stem cell transplantation;Couriel;Curr. Opin. Oncol.,2000

2. Electronic Medicines Compendium, 2015a. ‘Remsima 100mg powder for concentrate for solution for infusion’, (Summary of Product Characteristics). Available at https://www.medicines.org.uk/emc/medicine/29978. Updated 25/02/2015 (accessed 26.07.15).

3. Electronic Medicines Compendium, 2015b. ‘Remicade 100mg powder for concentrate for solution for infusion’, (Summary of Product Characteristics). Available at https://www.medicines.org.uk/emc/medicine/3236. Updated 29/05/2015 (accessed 26.07.15).

4. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumour necrosis factor from human monocytes;Espevik;J. Immunol. Methods,1986

5. Construction and initial characterization of a mouse-human chimeric anti-TNF antibody;Knight;Mol. Immunol.,1993

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged in-use physicochemical and biological stability of nivolumab and pembrolizumab diluted in saline infusion bags and in partially used medication vials;Journal of Oncology Pharmacy Practice;2024-08-30

2. Current Industry Best Practice on in-use Stability and Compatibility Studies for Biological Products;Journal of Pharmaceutical Sciences;2023-09

3. Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev^®), a bevacizumab biosimilar, under extended in-use conditions;Journal of Oncology Pharmacy Practice;2022-03-21

4. Physicochemical stability of PF-05280014 (trastuzumab-qyyp; Trazimera^TM), a trastuzumab biosimilar, under extended in-use conditions;Journal of Oncology Pharmacy Practice;2022-01-24

5. Do plasticized polyvinylchloride and polyurethane infusion sets promote infliximab adsorption?;Pharmaceutical Technology in Hospital Pharmacy;2020-05-26